चिन्ह | एक्सचेंज | करेंसी |
|---|
प्रकार | 5 मिनट | 15 मिनट | प्रति घंटा | दैनिक | मासिक |
|---|---|---|---|---|---|
| मूविंग एवरेज | बेचना | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय |
| तकनीकी संकेतक | बेचना | बेचना | बेचना | बेचना | मजबूत विक्रय |
| सारांश | बेचना | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय | मजबूत विक्रय |
नाम | अंतिम | उच्च | निम्न | बदलाव | बदलाव % | वॉल्यूम | समय | ||
|---|---|---|---|---|---|---|---|---|---|
| 1,209.95 | 1,242.00 | 1,121.15 | +46.70 | +4.01% | 259.43K | NSE | |||
| 334.95 | 341.50 | 328.00 | +2.80 | +0.84% | 736.00 | NSE | |||
| 24.20 | 24.95 | 23.40 | -0.40 | -1.63% | 21.58M | NSE | |||
| 49.90 | 53.60 | 45.10 | +4.25 | +9.31% | 41.26M | NSE | |||
| 57.55 | 59.30 | 56.60 | -1.40 | -2.37% | 360.52K | NSE | |||
| 3,106.00 | 3,268.00 | 3,060.00 | -55.65 | -1.76% | 1.31K | NSE | |||
| 139.00 | 148.40 | 134.75 | -5.95 | -4.10% | 250.04K | NSE | |||
| 127.75 | 129.70 | 124.75 | -0.95 | -0.74% | 25.96M | NSE | |||
| 742.35 | 759.00 | 736.10 | -11.65 | -1.55% | 3.35M | NSE | |||
| 747.75 | 759.60 | 740.00 | -7.40 | -0.98% | 11.66M | NSE | |||
| 446.55 | 468.00 | 441.30 | +0.95 | +0.21% | 721.36K | NSE | |||
| 184.45 | 185.60 | 181.75 | +1.60 | +0.88% | 5.73M | NSE | |||
| 334.35 | 343.10 | 327.45 | -5.50 | -1.62% | 427.35K | NSE | |||
| 2,722.25 | 2,783.00 | 2,699.00 | -46.00 | -1.66% | 3.09M | NSE | |||
| 9.90 | 10.60 | 9.75 | -0.35 | -3.41% | 8.10M | NSE |
Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. The company is developing pharmaceutical products, such as Lorazepam oral spray for acute seizures emergency treatment; Ketoconazole 2% topical ointment for treatment of skin fungal infections; and Metformin chewable/ sublingual tablets for treatment of type 2 diabetes. It is also developing natural products and dietary supplements, including E-drops Nano and PURALEN that are self-nanoemulsifying compositions containing natural essential oils for oral administration; Glucora, a soft gelatin capsule with Banaba extract in self-emulsifying formulation for oral administration; URBAN POWER, a soft gelatin capsule with Ursolic acid and Banaba extract in self-emulsifying formulation for oral administration; Vitamin D3 nanoemulsion, a nanoemulsion with cholecalciferol; and Cleanezze, a hand sanitizer containing oil. Eastgate Biotech Corp. has collaboration with Biotech Corp. to develop a vaccine against COVID-19. The company was formerly known as Eastgate Acquisitions Corporation and changed its name to Eastgate Biotech Corp. in December 2014. Eastgate Biotech Corp. was founded in 1999 and is based in Toronto, Canada.